Tag: Schizophrenia
COVID-19 Positivity Lower for Some With Psychiatric Disorders
Patients with schizophrenia, mood disorders, anxiety disorders have increased odds of COVID-19 mortality
Smartphone Intervention Feasible for Severe Mental Illness
Large effect sizes seen for Beck Depression Inventory, Recovery Assessment Scale, Rosenberg Self-Esteem Scale
Psychosocial Interventions Can Help Prevent Schizophrenia Relapse
Benefits seen for family interventions, family psychoeducation, and cognitive behavioral therapy
Pregnancy Complications Higher in Women With Schizophrenia
Women with schizophrenia also experience higher rates of delivery complications and neonatal complications versus women without mental disorders
Schizophrenia Tied to Higher Risk for Severe COVID-19
Risk higher despite lower infection risk and regardless of sociodemographic and medical factors
Better Attitudes Seen When ‘People With Schizophrenia’ Phrase Used
More authoritarian, more socially restrictive, less benevolent attitudes seen when patients are referred to as 'schizophrenic'
Cognitive Remediation Benefits Patients With Schizophrenia
Benefits include cognitive and functional outcomes even for severely affected patients
Model May ID Schizophrenia Cases by DNA Methylation in Blood
CoRSIV-based model, with a positive predictive value of 80 percent, surpassed the performance of a model based on polygenic risk score
Genetic Risk for Psychiatric Disorders Linked to Brain Changes
Polygenic risk scores for bipolar disorder and schizophrenia linked to structure and function of the ventromedial prefrontal cortex
Acceptability of Assessment App Low in Schizophrenia Patients
Thirty-one percent of participants with schizophrenia spectrum disorders installed app; app remained installed in 70 percent